Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Long

Showing results (641-650 of 658) with videos related to

Pageof 66
Sort By:
Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Journal of Geriatric Cardiology : JGC|November 16, 2023
Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history: a prospective propensity score-matched cohort studyWen-Li Dai, Zi-Xu Zhao, Chao Jiang, et al.
Pacing and Clinical Electrophysiology : PACE|February 26, 2024
Catheter ablation of atrial fibrillation in patients with left bundle branch blockRi-Bo Tang, Wen-He Lv, De-Yong Long, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Seminars in Thrombosis and Hemostasis|September 15, 2022
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated CardiomyopathyHao-Sheng Wu, Jian-Zeng Dong, Xin Du, et al.
Pacing and Clinical Electrophysiology : PACE|July 10, 2026
Comparison of Ablation Index-Guided Lesion Size in nGEN and SMARTABLATE: An Ex Vivo Porcine Heart StudyXin-Ru Li, Jie-Wen Yin, Xue-Si Wang, et al.
Journal of the American Heart Association|October 30, 2018
Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF StudyDi-Hui Lan, Chao Jiang, Xin Du, et al.
Scientific Reports|October 1, 2025
Safety and effectiveness of catheter ablation of atrial fibrillation in patients with mitral valve replacement mechanical versus bioprosthetic valvesXiao-Ying Liu, De-Yong Long, Jian-Zeng Dong, et al.
Clinical Cardiology|July 28, 2021
Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort studyYi-Kai Cui, Jian-Zeng Dong, Xin Du, et al.
Frontiers in Cardiovascular Medicine|June 27, 2025
Low-density lipoprotein cholesterol levels and in-hospital bleeding in patients with atrial fibrillation: findings from CCC-AF projectXue-Ying Tong, Jing Lin, Zhao-Qing Sun, et al.
Pageof 66

Showing results (641-650 of 658) with videos related to

Sort By:
Pageof 66
Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Journal of Geriatric Cardiology : JGC|November 16, 2023
Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history: a prospective propensity score-matched cohort studyWen-Li Dai, Zi-Xu Zhao, Chao Jiang, et al.
Pacing and Clinical Electrophysiology : PACE|February 26, 2024
Catheter ablation of atrial fibrillation in patients with left bundle branch blockRi-Bo Tang, Wen-He Lv, De-Yong Long, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Seminars in Thrombosis and Hemostasis|September 15, 2022
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated CardiomyopathyHao-Sheng Wu, Jian-Zeng Dong, Xin Du, et al.
Pacing and Clinical Electrophysiology : PACE|July 10, 2026
Comparison of Ablation Index-Guided Lesion Size in nGEN and SMARTABLATE: An Ex Vivo Porcine Heart StudyXin-Ru Li, Jie-Wen Yin, Xue-Si Wang, et al.
Journal of the American Heart Association|October 30, 2018
Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF StudyDi-Hui Lan, Chao Jiang, Xin Du, et al.
Scientific Reports|October 1, 2025
Safety and effectiveness of catheter ablation of atrial fibrillation in patients with mitral valve replacement mechanical versus bioprosthetic valvesXiao-Ying Liu, De-Yong Long, Jian-Zeng Dong, et al.
Clinical Cardiology|July 28, 2021
Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort studyYi-Kai Cui, Jian-Zeng Dong, Xin Du, et al.
Frontiers in Cardiovascular Medicine|June 27, 2025
Low-density lipoprotein cholesterol levels and in-hospital bleeding in patients with atrial fibrillation: findings from CCC-AF projectXue-Ying Tong, Jing Lin, Zhao-Qing Sun, et al.
Pageof 66